相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Current Concepts on the Pathogenesis of Systemic Sclerosis
Marie Elise Truchetet et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2023)
Current Perspectives on Gastrointestinal Models to Assess Probiotic-Pathogen Interactions
Mehreen Anjum et al.
FRONTIERS IN MICROBIOLOGY (2022)
Current advances in the treatment of systemic sclerosis
Heather Bukiri et al.
CURRENT OPINION IN PHARMACOLOGY (2022)
Bacteriocin-Producing Probiotic Lactic Acid Bacteria in Controlling Dysbiosis of the Gut Microbiota
Anjana et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)
The Yin and Yang of IL-17 in Systemic Sclerosis
Lanxuan Wei et al.
FRONTIERS IN IMMUNOLOGY (2022)
Plasma Metabolomic Profiling Reveals Four Possibly Disrupted Mechanisms in Systemic Sclerosis
Thomas Boegl et al.
BIOMEDICINES (2022)
Animal Models of Systemic Sclerosis: Using Nailfold Capillaroscopy as a Potential Tool to Evaluate Microcirculation and Microangiopathy: A Narrative Review
Angelica Mandujano et al.
LIFE-BASEL (2022)
Role of B-Cell in the Pathogenesis of Systemic Sclerosis
Benjamin Thoreau et al.
FRONTIERS IN IMMUNOLOGY (2022)
Type 1 interferon activation in systemic sclerosis: a biomarker, a target or the culprit
Vishal Kakkar et al.
CURRENT OPINION IN RHEUMATOLOGY (2022)
Gut microbiome in systemic sclerosis: a potential therapeutic target
Beata Polkowska-Pruszynska et al.
POSTEPY DERMATOLOGII I ALERGOLOGII (2022)
Low-Fat, High-Fiber Diet Reduces Markers of Inflammation and Dysbiosis and Improves Quality of Life in Patients With Ulcerative Colitis
Julia Fritsch et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
New Insights into Profibrotic Myofibroblast Formation in Systemic Sclerosis: When the Vascular Wall Becomes the Enemy
Eloisa Romano et al.
LIFE-BASEL (2021)
Fecal microbiome differs between patients with systemic sclerosis with and without small intestinal bacterial overgrowth
Daniel Levin et al.
JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2021)
The influence of the gut microbiota on the bioavailability of oral drugs
Xintong Zhang et al.
ACTA PHARMACEUTICA SINICA B (2021)
Effect of probiotics and gut microbiota on anti-cancer drugs: Mechanistic perspectives
Aja Badgeley et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)
Dysfunctional Keratinocytes Increase Dermal Inflammation in Systemic Sclerosis: Results From Studies Using Tissue-Engineered Scleroderma Epidermis
Barbara Russo et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Butyrate Improves Skin/Lung Fibrosis and Intestinal Dysbiosis in Bleomycin-Induced Mouse Models
Hee Jin Park et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Congruent microbiome signatures in fibrosis-prone autoimmune diseases: IgG4-related disease and systemic sclerosis
Damian R. Plichta et al.
GENOME MEDICINE (2021)
The microbiome and systemic sclerosis: A review of current evidence
Tze Chin Tan et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2021)
Endothelial-to-mesenchymal transition in systemic sclerosis
P. Di Benedetto et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2021)
B cells in systemic sclerosis: from pathophysiology to treatment
Konstantinos Melissaropoulos et al.
CLINICAL RHEUMATOLOGY (2021)
A review and roadmap of the skin, lung and gut microbiota in systemic sclerosis
Shannon Teaw et al.
RHEUMATOLOGY (2021)
Modulatory Effects of Probiotics During Pathogenic Infections With Emphasis on Immune Regulation
Abdul Raheem et al.
FRONTIERS IN IMMUNOLOGY (2021)
TGFβ promotes low IL10-producing ILC2 with profibrotic ability involved in skin fibrosis in systemic sclerosis
Paoline Laurent et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Idiopathic pulmonary fibrosis and systemic sclerosis: pathogenic mechanisms and therapeutic interventions
Hamid Mattoo et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
Advances in epigenetics in systemic sclerosis: molecular mechanisms and therapeutic potential
Pei-Suen Tsou et al.
NATURE REVIEWS RHEUMATOLOGY (2021)
Safety and efficacy of faecal microbiota transplantation by Anaerobic Cultivated Human Intestinal Microbiome (ACHIM) in patients with systemic sclerosis: study protocol for the randomised controlled phase II ReSScue trial
Anna-Maria Hoffmann-Vold et al.
BMJ OPEN (2021)
Gut Microbiota Aberration in Patients of Systemic Sclerosis and Bleomycin-Induced Mice Model
Jungen Tang et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)
Oral Lactobacillus Species in Systemic Sclerosis
Daniela Melchiorre et al.
MICROORGANISMS (2021)
Gut-Brain Connection: Microbiome, Gut Barrier, and Environmental Sensors
Min-Gyu Gwak et al.
IMMUNE NETWORK (2021)
Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions?
Cezmi A. Akdis
NATURE REVIEWS IMMUNOLOGY (2021)
IL-17A Dissociates Inflammation from Fibrogenesis in Systemic Sclerosis
Aleksandra Maria Dufour et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2020)
Effectiveness of Saccharomyces boulardii and Metronidazole for Small Intestinal Bacterial Overgrowth in Systemic Sclerosis
Grettel Garcia-Collinot et al.
DIGESTIVE DISEASES AND SCIENCES (2020)
Global skin gene expression analysis of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profile
Brian Skaug et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
The potential of fecal microbiota transplantation in systemic sclerosis
Anna-Maria Hoffmann-Vold et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2020)
Nintedanib: New indication for systemic sclerosis-associated interstitial lung disease
Masataka Kuwana et al.
MODERN RHEUMATOLOGY (2020)
Raynaud phenomenon and digital ulcers in systemic sclerosis
Michael Hughes et al.
NATURE REVIEWS RHEUMATOLOGY (2020)
Cytotoxic CD4+ T lymphocytes may induce endothelial cell apoptosis in systemic sclerosis
Takashi Maehara et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Fecal microbiota transplantation in systemic sclerosis: A double-blind, placebo-controlled randomized pilot trial
Havard Fretheim et al.
PLOS ONE (2020)
T cells in SSc skin lesions: knowing your enemy
Patrizia Fuschiotti
NATURE REVIEWS RHEUMATOLOGY (2020)
Role of Alarmins in the Pathogenesis of Systemic Sclerosis
Antonello Giovannetti et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Systemic Sclerosis Perturbs the Architecture of the Immunome
Bhairav Paleja et al.
FRONTIERS IN IMMUNOLOGY (2020)
Circulating microbial small RNAs are altered in patients with rheumatoid arthritis
Michelle J. Ormseth et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer
Winnie Fong et al.
ONCOGENE (2020)
Fibrosis: from mechanisms to medicines
Neil C. Henderson et al.
NATURE (2020)
The contribution of mesenchymal transitions to the pathogenesis of systemic sclerosis
Irene Rosa et al.
EUROPEAN JOURNAL OF RHEUMATOLOGY (2020)
The Role of Butyrate in Attenuating Pathobiont-Induced Hyperinflammation
Jiezhong Chen et al.
IMMUNE NETWORK (2020)
Circulating follicular helper T cells are increased in systemic sclerosis and promote plasmablast differentiation through the IL-21 pathway which can be inhibited by ruxolitinib
Laure Ricard et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
PU.1 controls fibroblast polarization and tissue fibrosis
Thomas Wohlfahrt et al.
NATURE (2019)
Evolving insights into the cellular and molecular pathogenesis of fibrosis in systemic sclerosis
Benjamin Korman
TRANSLATIONAL RESEARCH (2019)
Pathophysiology of systemic sclerosis: current understanding and new insights
Maurizio Cutolo et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2019)
Involvement of the myeloid cell compartment in fibrogenesis and systemic sclerosis
Gabriela Kania et al.
NATURE REVIEWS RHEUMATOLOGY (2019)
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease
Oliver Distler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Effect of probiotics on gastrointestinal symptoms and immune parameters in systemic sclerosis: a randomized placebo-controlled trial
Thais Fernandes Marighela et al.
RHEUMATOLOGY (2019)
A double-blind randomized placebo-controlled trial of probiotics in systemic sclerosis associated gastrointestinal disease
Andrea Hsiu Ling Low et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2019)
CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-α production in systemic sclerosis
Roberto Lande et al.
NATURE COMMUNICATIONS (2019)
The Roles of IL-1 Family Cytokines in the Pathogenesis of Systemic Sclerosis
Dan Xu et al.
FRONTIERS IN IMMUNOLOGY (2019)
Gastrointestinal involvement in systemic sclerosis: an update
Zsuzsanna H. McMahan
CURRENT OPINION IN RHEUMATOLOGY (2019)
Shared and distinct mechanisms of fibrosis
Joerg H. W. Distler et al.
NATURE REVIEWS RHEUMATOLOGY (2019)
Interplay between the human gut microbiome and host metabolism
Alessia Visconti et al.
NATURE COMMUNICATIONS (2019)
The immunopathogenesis of fibrosis in systemic sclerosis
M. Brown et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2019)
The efficacy of dietary intervention on gastrointestinal involvement in systemic sclerosis: A systematic literature review
Elizabeth Smith et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2019)
Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary Fibrosis
David N. O'Dwyer et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Gut Disease in Systemic Sclerosis-New Approaches to Common Problems
Jessica Zhu et al.
CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY (2019)
Microbiome dysbiosis is associated with disease duration and increased inflammatory gene expression in systemic sclerosis skin
Michael E. Johnson et al.
ARTHRITIS RESEARCH & THERAPY (2019)
Elevated serum levels of interleukin-1β and interleukin-33 in patients with systemic sclerosis in Chinese population
Y. -J. Zhang et al.
ZEITSCHRIFT FUR RHEUMATOLOGIE (2018)
The Inhibition Effect of Lactobacilli Against Growth and Biofilm Formation of Pseudomonas aeruginosa
Dariush Shokri et al.
PROBIOTICS AND ANTIMICROBIAL PROTEINS (2018)
Microbial and metabolic multi-omic correlations in systemic sclerosis patients
Chiara Bellocchi et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2018)
Soluble CD163 as a Potential Biomarker in Systemic Sclerosis
Camelia Frantz et al.
DISEASE MARKERS (2018)
Is there a role for IL-17 in the pathogenesis of systemic sclerosis?
Carlo Chizzolini et al.
IMMUNOLOGY LETTERS (2018)
Endogenous ligands of TLR4 promote unresolving tissue fibrosis: Implications for systemic sclerosis and its targeted therapy
Swati Bhattacharyya et al.
IMMUNOLOGY LETTERS (2018)
Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8
Marie Dominique Ah Kioon et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Intestinal Microbiota Influences Non-intestinal Related Autoimmune Diseases
Maria C. Opazo et al.
FRONTIERS IN MICROBIOLOGY (2018)
IL-1-IL-17 Signaling Axis Contributes to Fibrosis and Inflammation in Two Different Murine Models of Systemic Sclerosis
Min-Jung Park et al.
FRONTIERS IN IMMUNOLOGY (2018)
Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies
Concetta Panebianco et al.
MICROBIOME (2018)
BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance
Takashi Matsushita et al.
SCIENCE ADVANCES (2018)
Imbalance between T helper 17 and regulatory T cell subsets plays a significant role in the pathogenesis of systemic sclerosis
Cuiling Mo et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Innate Immunity in Systemic Sclerosis Fibrosis: Recent Advances
Paoline Laurent et al.
FRONTIERS IN IMMUNOLOGY (2018)
Anti-inflammatory and Antioxidant Properties of Probiotic Bacterium Lactobacillus mucosae AN1 and Lactobacillus fermentum SNR1 Wistar Albino Rats
Repally Ayyanna et al.
FRONTIERS IN MICROBIOLOGY (2018)
Interleukin-33 in Systemic Sclerosis: Expression and Pathogenesis
Liya Li et al.
FRONTIERS IN IMMUNOLOGY (2018)
Regulatory T Cells in Systemic Sclerosis
Camelia Frantz et al.
FRONTIERS IN IMMUNOLOGY (2018)
Impaired diversity of the lung microbiome predicts progression of idiopathic pulmonary fibrosis
Youhei Takahashi et al.
RESPIRATORY RESEARCH (2018)
Oligosaccharide biotechnology: an approach of prebiotic revolution on the industry
Mario Cezar Rodrigues Mano et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2018)
Regulatory T Cells in Systemic Sclerosis: a Comprehensive Review
Gleb Slobodin et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2017)
Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health
Carl D. Koch et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
Systemic Sclerosis Dermal Fibroblasts Suppress Th1 Cytokine Production via Galectin-9 Overproduction due to Fli1 Deficiency
Ryosuke Saigusa et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Early-Life Antibiotic Exposure Causes Intestinal Dysbiosis and Exacerbates Skin and Lung Pathology in Experimental Systemic Sclerosis
Heena Mehta et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Microbiota and reproducibility of rodent models
Craig L. Franklin et al.
LAB ANIMAL (2017)
Endothelial cell-specific activation of transforming growth factor-β signaling in mice induces cutaneous, visceral, and microvascular fibrosis
Peter J. Wermuth et al.
LABORATORY INVESTIGATION (2017)
High Fat Diet Alters Gut Microbiota and the Expression of Paneth Cell-Antimicrobial Peptides Preceding Changes of Circulating Inflammatory Cytokines
Xiulan Guo et al.
MEDIATORS OF INFLAMMATION (2017)
The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics
Glenn R. Gibson et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
Leore T. Geller et al.
SCIENCE (2017)
The role of platelets in autoimmunity, vasculopathy, and fibrosis: Implications for systemic sclerosis
Konstantinos Ntelis et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2017)
The molecular basis of endothelial cell plasticity
Elisabetta Dejana et al.
NATURE COMMUNICATIONS (2017)
Strain-specific probiotic properties of lactic acid bacteria and their interference with human intestinal pathogens invasion
Raffaella Campana et al.
GUT PATHOGENS (2017)
A novel multi-network approach reveals tissue-specific cellular modulators of fibrosis in systemic sclerosis
Jaclyn N. Taroni et al.
GENOME MEDICINE (2017)
Scleroderma Peripheral B Lymphocytes Secrete Interleukin-6 and Transforming Growth Factor β and Activate Fibroblasts
Nicolas Dumoitier et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Gut microbiota profile in systemic sclerosis patients with and without clinical evidence of gastrointestinal involvement
Vania Patrone et al.
SCIENTIFIC REPORTS (2017)
Increased proportions of functionally impaired regulatory T cell subsets in systemic sclerosis
Emese Ugor et al.
CLINICAL IMMUNOLOGY (2017)
Intestinal microbiome in scleroderma: recent progress
Elizabeth R. Volkmann
CURRENT OPINION IN RHEUMATOLOGY (2017)
Systemic sclerosis is associated with specific alterations in gastrointestinal microbiota in two independent cohorts
Elizabeth R. Volkmann et al.
BMJ OPEN GASTROENTEROLOGY (2017)
Inhibition of phosphodiesterase 4 (PDE4) reduces dermal fibrosis by interfering with the release of interleukin-6 from M2 macrophages
Christiane Maier et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
IL-22 capacitates dermal fibroblast responses to TNF in scleroderma
Nicolo Costantino Brembilla et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Role of muscarinic-3 receptor antibody in systemic sclerosis: correlation with disease duration and effects of IVIG
Sumit Kumar et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2016)
Animal models of scleroderma: recent progress
Roberta G. Marangoni et al.
CURRENT OPINION IN RHEUMATOLOGY (2016)
The Lung Microbiome, Immunity, and the Pathogenesis of Chronic Lung Disease
David N. O'Dwyer et al.
JOURNAL OF IMMUNOLOGY (2016)
Association of Systemic Sclerosis With a Unique Colonic Microbial Consortium
Elizabeth R. Volkmann et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Platelets Induce Thymic Stromal Lymphopoietin Production by Endothelial Cells: Contribution to Fibrosis in Human Systemic Sclerosis
Marie-Elise Truchetet et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Breg Cells Are Numerically Decreased and Functionally Impaired in Patients With Systemic Sclerosis
Athanasios Mavropoulos et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Immune-microbiota interactions in health and disease
Noah W. Palm et al.
CLINICAL IMMUNOLOGY (2015)
Risk and Safety of Probiotics
Shira Doron et al.
CLINICAL INFECTIOUS DISEASES (2015)
Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis
Katherine G. MacDonald et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist
Paola Cipriani et al.
JOURNAL OF RHEUMATOLOGY (2015)
Fructose Malabsorption in Systemic Sclerosis
Isabelle Marie et al.
MEDICINE (2015)
Cellular and molecular mechanisms in the pathophysiology of systemic sclerosis
T. Hua-Huy et al.
PATHOLOGIE BIOLOGIE (2015)
Identification and isolation of a dermal lineage with intrinsic fibrogenic potential
Yuval Rinkevich et al.
SCIENCE (2015)
The role of the acquired immune response in systemic sclerosis
Carlo Chizzolini et al.
SEMINARS IN IMMUNOPATHOLOGY (2015)
Analysis of the Upper Respiratory Tract Microbiotas as the Source of the Lung and Gastric Microbiotas in Healthy Individuals
Christine M. Bassis et al.
MBIO (2015)
Systems Level Analysis of Systemic Sclerosis Shows a Network of Immune and Profibrotic Pathways Connected with Genetic Polymorphisms
J. Matthew Mahoney et al.
PLOS COMPUTATIONAL BIOLOGY (2015)
Pathogenesis of systemic sclerosis
Debendra Pattanaik et al.
FRONTIERS IN IMMUNOLOGY (2015)
Systemic sclerosis
Yannick Allanore et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Evidence for oesophageal and anorectal involvement in very early systemic sclerosis (VEDOSS): report from a single VEDOSS/EUSTAR centre
Gemma Lepri et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
The Role of Bacteria in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis
Phillip L. Molyneaux et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Oxidative Stress Elicits Platelet/Leukocyte Inflammatory Interactions via HMGB1: A Candidate for Microvessel Injury in Sytemic Sclerosis
Norma Maugeri et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Plasmacytoid Dendritic Cells Mediate Anti-inflammatory Responses to a Gut Commensal Molecule via Both Innate and Adaptive Mechanisms
Suryasarathi Dasgupta et al.
CELL HOST & MICROBE (2014)
Gut Dysbiosis Promotes M2 Macrophage Polarization and Allergic Airway Inflammation via Fungi-Induced PGE2
Yun-Gi Kim et al.
CELL HOST & MICROBE (2014)
Molecular dialogue between the human gut microbiota and the host: a Lactobacillus and Bifidobacterium perspective
Francesca Turroni et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Skin Wound Healing Is Accelerated and Scarless in the Absence of Commensal Microbiota
Maria C. C. Canesso et al.
JOURNAL OF IMMUNOLOGY (2014)
High Rhodotorula Sequences in Skin Transcriptome of Patients with Diffuse Systemic Sclerosis
Sarah T. Arron et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Transforming growth factor β-at the centre of systemic sclerosis
Robert Lafyatis
NATURE REVIEWS RHEUMATOLOGY (2014)
Correction: Molecular Subsets in the Gene Expression Signatures of Scleroderma Skin
Ausra Milano et al.
PLoS One (2014)
Administration of a Probiotic Can Change Drug Pharmacokinetics: Effect of E. coli Nissle 1917 on Amidarone Absorption in Rats
Zuzana Matuskova et al.
PLOS ONE (2014)
FibronectinEDA Promotes Chronic Cutaneous Fibrosis Through Toll-like Receptor Signaling
Swati Bhattacharyya et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Chronic Toll-like receptor 4 stimulation in skin induces inflammation, macrophage activation, transforming growth factor beta signature gene expression, and fibrosis
Giuseppina Stifano et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Interleukin-17A promotes functional activation of systemic sclerosis patient-derived dermal vascular smooth muscle cells by extracellular-regulated protein kinases signalling pathway
Mengguo Liu et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Identification of Cadherin 11 as a Mediator of Dermal Fibrosis and Possible Role in Systemic Sclerosis
Minghua Wu et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Increased serum IL-33 levels may indicate vascular involvement in systemic sclerosis
Sarah Terras et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Toll-like receptor-mediated, enhanced production of profibrotic TIMP-1 in monocytes from patients with systemic sclerosis: role of serum factors
Marzena Ciechomska et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Interleukin-13-producing CD8+T cells mediate dermal fibrosis in patients with systemic sclerosis
Patrizia Fuschiotti et al.
ARTHRITIS AND RHEUMATISM (2013)
Role of Interleukin-13 in fibrosis, particularly systemic sclerosis
Steven O'Reilly
BIOFACTORS (2013)
A Single Strain of Clostridium butyricum Induces Intestinal IL-10-Producing Macrophages to Suppress Acute Experimental Colitis in Mice
Atsushi Hayashi et al.
CELL HOST & MICROBE (2013)
IL-1β and TGFβ2 synergistically induce endothelial to mesenchymal transition in an NFκB-dependent manner
Monika Maleszewska et al.
IMMUNOBIOLOGY (2013)
Serum levels of interleukin-1 in patients with systemic sclerosis
Takeo Maekawa et al.
JOURNAL OF DERMATOLOGY (2013)
Molecular Signatures in Skin Associated with Clinical Improvement during Mycophenolate Treatment in Systemic Sclerosis
Monique Hinchcliff et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota
Koji Atarashi et al.
NATURE (2013)
IL-17A Induces Endothelial Inflammation in Systemic Sclerosis via the ERK Signaling Pathway
Xiaojing Xing et al.
PLOS ONE (2013)
Gastrointestinal complications of systemic sclerosis
Xin-Ping Tian et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis
Antoine Francois et al.
ARTHRITIS RESEARCH & THERAPY (2013)
B cells tell scleroderma fibroblasts to produce collagen
Dimitrios Daoussis et al.
ARTHRITIS RESEARCH & THERAPY (2013)
The role of type 1 interferon in systemic sclerosis
Minghua Wu et al.
FRONTIERS IN IMMUNOLOGY (2013)
Direct isolation of myofibroblasts and fibroblasts from bleomycin-injured lungs reveals their functional similarities and differences
Taisuke Akamatsu et al.
FIBROGENESIS & TISSUE REPAIR (2013)
A rare polymorphism in the gene for Toll-like receptor 2 is associated with systemic sclerosis phenotype and increases the production of inflammatory mediators
J. C. A. Broen et al.
ARTHRITIS AND RHEUMATISM (2012)
Potential roles of interleukin-17A in the development of skin fibrosis in mice
Yoshinobu Okamoto et al.
ARTHRITIS AND RHEUMATISM (2012)
Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis
Heidi H. Kong et al.
GENOME RESEARCH (2012)
Intrinsic Gene Expression Subsets of Diffuse Cutaneous Systemic Sclerosis Are Stable in Serial Skin Biopsies
Sarah A. Pendergrass et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Gut fibrosis with altered colonic contractility in a mouse model of scleroderma
Nora M. Thoua et al.
RHEUMATOLOGY (2012)
Host-Gut Microbiota Metabolic Interactions
Jeremy K. Nicholson et al.
SCIENCE (2012)
Serum IL-33 levels are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis
Koichi Yanaba et al.
CLINICAL RHEUMATOLOGY (2011)
Platelet-derived serotonin links vascular disease and tissue fibrosis
Clara Dees et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Blocking IL-17A Promotes the Resolution of Pulmonary Inflammation and Fibrosis Via TGF-β1-Dependent and -Independent Mechanisms
Su Mi et al.
JOURNAL OF IMMUNOLOGY (2011)
The skin microbiome
Elizabeth A. Grice et al.
NATURE REVIEWS MICROBIOLOGY (2011)
The Toll-Like Receptor 2 Pathway Establishes Colonization by a Commensal of the Human Microbiota
June L. Round et al.
SCIENCE (2011)
Toll-like receptor 3 upregulation by type I interferon in healthy and scleroderma dermal fibroblasts
Sandeep K. Agarwal et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Cooperative interaction of CTGF and TGF-beta in animal models of fibrotic disease
Qingjian Wang et al.
FIBROGENESIS & TISSUE REPAIR (2011)
The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis
Mirko Manetti et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Systemic Sclerosis and Lupus Points in an Interferon-Mediated Continuum
Shervin Assassi et al.
ARTHRITIS AND RHEUMATISM (2010)
Bleomycin and IL-1β-mediated pulmonary fibrosis is IL-17A dependent
Mark S. Wilson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
IL-33 Induces IL-13-Dependent Cutaneous Fibrosis
Andrew L. Rankin et al.
JOURNAL OF IMMUNOLOGY (2010)
IL-17-producing human peripheral regulatory T cells retain suppressive function
Gaelle Beriou et al.
BLOOD (2009)
Clinical Significance of Serum HMGB-1 and sRAGE Levels in Systemic Sclerosis: Association with Disease Severity
Ayumi Yoshizaki et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2009)
IL-33 Amplifies the Polarization of Alternatively Activated Macrophages That Contribute to Airway Inflammation
Mariola Kurowska-Stolarska et al.
JOURNAL OF IMMUNOLOGY (2009)
Commensal bacteria regulate Toll-like receptor 3-dependent inflammation after skin injury
Yuping Lai et al.
NATURE MEDICINE (2009)
Induction of interferon-α by scleroderma sera containing autoantibodies to topoisomerase I
Daniel Kim et al.
ARTHRITIS AND RHEUMATISM (2008)
The IL-6 promoter polymorphism is associated with disease activity and disability in systemic sclerosis
Roxana Sfrent-Cornateanu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2006)
Elevated serum BAFF levels in patients with systemic sclerosis - Enhanced BAFF signaling in systemic sclerosis B lymphocytes
T Matsushita et al.
ARTHRITIS AND RHEUMATISM (2006)
pH-, lactic acid-, and non-lactic acid-dependent activities of probiotic lactobacilli against Salmonella enterica serovar typhimurium
D Fayol-Messaoudi et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2005)
Alterations of mononuclear inflammatory cells, CD4/CD8+T cells, interleukin 1β, and tumour necrosis factor a in the bronchoalveolar lavage fluid, peripheral blood, and skin of patients with systemic sclerosis
MR Hussein et al.
JOURNAL OF CLINICAL PATHOLOGY (2005)
Fibrotic disease and the TH1/TH2 paradigm
TA Wynn
NATURE REVIEWS IMMUNOLOGY (2004)
Differential effects of short-chain fatty acids on proliferation and production of pro- and anti-inflammatory cytokines by cultured lymphocytes
CR Cavaglieri et al.
LIFE SCIENCES (2003)
Function blocking autoantibodies against matrix metalloproteinase-1 in patients with systemic sclerosis
S Sato et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis
S Sato et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2001)
Sildenafil inhibits gastroduodenal motility
M Bortolotti et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2001)